Is Moderna Winning the COVID-19 Vaccine Race? ETFs to Gain

Moderna, Inc. MRNA raised hopes of a coronavirus vaccine amid these desperate times after it informed about positive interim data from a phase I study evaluating its mRNA-based coronavirus vaccine candidate, mRNA-1273, on May 18. The results reflected ...

from Google Alert - Business https://ift.tt/2zQGZf3
Moderna, Inc. MRNA raised hopes of a coronavirus vaccine amid these desperate times after it informed about positive interim data from a phase I study evaluating its mRNA-based coronavirus vaccine candidate, mRNA-1273, on May 18. The results reflected ... https://ift.tt/eA8V8J

Comments

Popular posts from this blog

Jobless Rate Drops

Electrolytic Fixed Power Capacitors Market Competitive intelligence & regional outlook 2020

USU project among finalists for $3 million solar energy tech prize